{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:25:04Z","timestamp":1772119504595,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,9,21]],"date-time":"2014-09-21T00:00:00Z","timestamp":1411257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s10585-014-9681-2","type":"journal-article","created":{"date-parts":[[2014,9,20]],"date-time":"2014-09-20T00:22:33Z","timestamp":1411172553000},"page":"935-944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors"],"prefix":"10.1007","volume":"31","author":[{"given":"Scott K.","family":"Sherman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica E.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer C.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Bellizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sue O\u2019Dorisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"O\u2019Dorisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,21]]},"reference":[{"issue":"18","key":"9681_CR1","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB (2008) One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063\u20133072. doi: 10.1200\/JCO.2007.15.4377","journal-title":"J Clin Oncol"},{"issue":"1","key":"9681_CR2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","volume":"9","author":"IM Modlin","year":"2008","unstructured":"Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9(1):61\u201372. doi: 10.1016\/S1470-2045(07)70410-2","journal-title":"Lancet Oncol"},{"issue":"3","key":"9681_CR3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archsurg.2010.10","volume":"145","author":"SC Wang","year":"2010","unstructured":"Wang SC, Parekh JR, Zuraek MB, Venook AP, Bergsland EK, Warren RS, Nakakura EK (2010) Identification of unknown primary tumors in patients with neuroendocrine liver metastases. Arch Surg 145(3):276\u2013280. doi: 10.1001\/archsurg.2010.10","journal-title":"Arch Surg"},{"key":"9681_CR4","doi-asserted-by":"crossref","unstructured":"Oberg K, Knigge U, Kwekkeboom D, Perren A (2012) Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii124\u2013130. doi: 10.1093\/annonc\/mds295","DOI":"10.1093\/annonc\/mds295"},{"issue":"6","key":"9681_CR5","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1245\/s10434-012-2836-y","volume":"20","author":"FS Dahdaleh","year":"2013","unstructured":"Dahdaleh FS, Lorenzen A, Rajput M, Carr JC, Liao J, Menda Y, O\u2019Dorisio TM, Howe JR (2013) The value of preoperative imaging in small bowel neuroendocrine tumors. Ann Surg Oncol 20(6):1912\u20131917. doi: 10.1245\/s10434-012-2836-y","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"9681_CR6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00259-009-1205-y","volume":"37","author":"V Prasad","year":"2010","unstructured":"Prasad V, Ambrosini V, Hommann M, Hoersch D, Fanti S, Baum RP (2010) Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET\/CT. Eur J Nucl Med Mol Imaging 37(1):67\u201377. doi: 10.1007\/s00259-009-1205-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"9681_CR7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jss.2013.04.008","volume":"184","author":"EK Bartlett","year":"2013","unstructured":"Bartlett EK, Roses RE, Gupta M, Shah PK, Shah KK, Zaheer S, Wachtel H, Kelz RR, Karakousis GC, Fraker DL (2013) Surgery for metastatic neuroendocrine tumors with occult primaries. J Surg Res 184(1):221\u2013227. doi: 10.1016\/j.jss.2013.04.008","journal-title":"J Surg Res"},{"issue":"28","key":"9681_CR8","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","volume":"27","author":"A Rinke","year":"2009","unstructured":"Rinke A, Muller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, Mayer C, Aminossadati B, Pape UF, Blaker M, Harder J, Arnold C, Gress T, Arnold R (2009) Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 27(28):4656\u20134663. doi: 10.1200\/JCO.2009.22.8510","journal-title":"J Clin Oncol"},{"issue":"8","key":"9681_CR9","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.ejca.2012.12.022","volume":"49","author":"CM Korse","year":"2013","unstructured":"Korse CM, Taal BG, van Velthuysen ML, Visser O (2013) Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry. Eur J Cancer 49(8):1975\u20131983. doi: 10.1016\/j.ejca.2012.12.022","journal-title":"Eur J Cancer"},{"issue":"1","key":"9681_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","volume":"197","author":"JM Sarmiento","year":"2003","unstructured":"Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG (2003) Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 197(1):29\u201337. doi: 10.1016\/S1072-7515(03)00230-8","journal-title":"J Am Coll Surg"},{"issue":"12","key":"9681_CR11","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1245\/s10434-010-1154-5","volume":"17","author":"SC Mayo","year":"2010","unstructured":"Mayo SC, de Jong MC, Pulitano C, Clary BM, Reddy SK, Gamblin TC, Celinksi SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Ferrero A, Schulick RD, Choti MA, Mentha G, Strub J, Bauer TW, Adams RB, Aldrighetti L, Capussotti L, Pawlik TM (2010) Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol 17(12):3129\u20133136. doi: 10.1245\/s10434-010-1154-5","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"9681_CR12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00259-012-2330-6","volume":"40","author":"JJ Zaknun","year":"2013","unstructured":"Zaknun JJ, Bodei L, Mueller-Brand J, Pavel ME, Baum RP, Horsch D, O\u2019Dorisio MS, O\u2019Dorisiol TM, Howe JR, Cremonesi M, Kwekkeboom DJ (2013) The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging 40(5):800\u2013816. doi: 10.1007\/s00259-012-2330-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9681_CR13","doi-asserted-by":"crossref","unstructured":"Givi B, Pommier SJ, Thompson AK, Diggs BS, Pommier RF (2006) Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival. Surgery 140 (6):891\u2013897; discussion 897\u2013898. doi: 10.1016\/j.surg.2006.07.033","DOI":"10.1016\/j.surg.2006.07.033"},{"issue":"4","key":"9681_CR14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/cncr.24065","volume":"115","author":"JS Hill","year":"2009","unstructured":"Hill JS, McPhee JT, McDade TP, Zhou Z, Sullivan ME, Whalen GF, Tseng JF (2009) Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer 115(4):741\u2013751. doi: 10.1002\/cncr.24065","journal-title":"Cancer"},{"issue":"4","key":"9681_CR15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000324770","volume":"93","author":"G Capurso","year":"2011","unstructured":"Capurso G, Bettini R, Rinzivillo M, Boninsegna L, Delle Fave G, Falconi M (2011) Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review. Neuroendocrinology 93(4):223\u2013229. doi: 10.1159\/000324770","journal-title":"Neuroendocrinology"},{"issue":"11","key":"9681_CR16","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/bjs.8842","volume":"99","author":"G Capurso","year":"2012","unstructured":"Capurso G, Rinzivillo M, Bettini R, Boninsegna L, Delle Fave G, Falconi M (2012) Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases. Br J Surg 99(11):1480\u20131486. doi: 10.1002\/bjs.8842","journal-title":"Br J Surg"},{"issue":"2","key":"9681_CR17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4158\/EP13262.RA","volume":"20","author":"JR Strosberg","year":"2013","unstructured":"Strosberg JR (2013) Systemic treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current approaches and future options. Endocr Pract 20(2):167\u2013175. doi: 10.4158\/EP13262.RA","journal-title":"Endocr Pract"},{"issue":"6","key":"9681_CR18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","volume":"364","author":"JC Yao","year":"2011","unstructured":"Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, Lebwohl D, Oberg K (2011) Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 364(6):514\u2013523. doi: 10.1056\/NEJMoa1009290","journal-title":"N Engl J Med"},{"issue":"6","key":"9681_CR19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","volume":"364","author":"E Raymond","year":"2011","unstructured":"Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A, Chen JS, Horsch D, Hammel P, Wiedenmann B, Van Cutsem E, Patyna S, Lu DR, Blanckmeister C, Chao R, Ruszniewski P (2011) Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 364(6):501\u2013513. doi: 10.1056\/NEJMoa1003825","journal-title":"N Engl J Med"},{"issue":"11","key":"9681_CR20","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1158\/1078-0432.CCR-12-3458","volume":"19","author":"K Oberg","year":"2013","unstructured":"Oberg K, Casanovas O, Castano JP, Chung D, Delle Fave G, Denefle P, Harris P, Khan MS, Kulke MH, Scarpa A, Tang LH, Wiedenmann B (2013) Molecular pathogenesis of neuroendocrine tumors: implications for current and future therapeutic approaches. Clin Cancer Res 19(11):2842\u20132849. doi: 10.1158\/1078-0432.CCR-12-3458","journal-title":"Clin Cancer Res"},{"issue":"6","key":"9681_CR21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1345\/aph.1Q729","volume":"46","author":"A Ganetsky","year":"2012","unstructured":"Ganetsky A, Bhatt V (2012) Gastroenteropancreatic neuroendocrine tumors: update on therapeutics. Ann Pharmacother 46(6):851\u2013862. doi: 10.1345\/aph.1Q729","journal-title":"Ann Pharmacother"},{"issue":"4","key":"9681_CR22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.soc.2013.06.012","volume":"22","author":"SK Sherman","year":"2013","unstructured":"Sherman SK, Howe JR (2013) Translational research in endocrine surgery. Surg Oncol Clin N Am 22(4):857\u2013884. doi: 10.1016\/j.soc.2013.06.012","journal-title":"Surg Oncol Clin N Am"},{"issue":"5","key":"9681_CR23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAP.0b013e3182a2dc67","volume":"20","author":"AM Bellizzi","year":"2013","unstructured":"Bellizzi AM (2013) Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry. Adv Anat Pathol 20(5):285\u2013314. doi: 10.1097\/PAP.0b013e3182a2dc67","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"9681_CR24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/modpathol.2012.34","volume":"25","author":"J Koo","year":"2012","unstructured":"Koo J, Mertens RB, Mirocha JM, Wang HL, Dhall D (2012) Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin. Mod Pathol 25(6):893\u2013901. doi: 10.1038\/modpathol.2012.34","journal-title":"Mod Pathol"},{"key":"9681_CR25","author":"SE Kerr","year":"2013","unstructured":"Kerr SE, Schnabel CA, Sullivan PS, Zhang Y, Huang VJ, Erlander MG, Brachtel EF, Dry SM (2013) A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors. Mod Pathol. doi: 10.1038\/modpathol.2013.105","journal-title":"Mod Pathol"},{"issue":"14","key":"9681_CR26","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1158\/1078-0432.CCR-12-0920","volume":"18","author":"SE Kerr","year":"2012","unstructured":"Kerr SE, Schnabel CA, Sullivan PS, Zhang Y, Singh V, Carey B, Erlander MG, Highsmith WE, Dry SM, Brachtel EF (2012) Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier. Clin Cancer Res 18(14):3952\u20133960. doi: 10.1158\/1078-0432.CCR-12-0920","journal-title":"Clin Cancer Res"},{"issue":"7","key":"9681_CR27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10585-011-9397-5","volume":"28","author":"N Posorski","year":"2011","unstructured":"Posorski N, Kaemmerer D, Ernst G, Grabowski P, Hoersch D, Hommann M, von Eggeling F (2011) Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases. Clin Exp Metastasis 28(7):637\u2013647. doi: 10.1007\/s10585-011-9397-5","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"9681_CR28","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.surg.2012.08.040","volume":"152","author":"JC Carr","year":"2012","unstructured":"Carr JC, Boese EA, Spanheimer PM, Dahdaleh FS, Martin M, Calva D, Schafer B, Thole DM, Braun T, O\u2019Dorisio TM, O\u2019Dorisio MS, Howe JR (2012) Differentiation of small bowel and pancreatic neuroendocrine tumors by gene-expression profiling. Surgery 152(6):998\u20131007. doi: 10.1016\/j.surg.2012.08.040","journal-title":"Surgery"},{"issue":"Suppl 3","key":"9681_CR29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1245\/s10434-013-3318-6","volume":"20","author":"JC Carr","year":"2013","unstructured":"Carr JC, Sherman SK, Wang D, Dahdaleh FS, Bellizzi AM, O\u2019Dorisio MS, O\u2019Dorisio TM, Howe JR (2013) Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors. Ann Surg Oncol 20(Suppl 3):739\u2013746. doi: 10.1245\/s10434-013-3318-6","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"9681_CR30","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.surg.2013.04.052","volume":"154","author":"SK Sherman","year":"2013","unstructured":"Sherman SK, Carr JC, Wang D, O\u2019Dorisio MS, O\u2019Dorisio TM, Howe JR (2013) Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors. Surgery 154(6):1206\u20131214. doi: 10.1016\/j.surg.2013.04.052","journal-title":"Surgery"},{"issue":"3","key":"9681_CR31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1245\/s10434-011-1997-4","volume":"19","author":"FS Dahdaleh","year":"2012","unstructured":"Dahdaleh FS, Calva-Cerqueira D, Carr JC, Liao J, Mezhir JJ, O\u2019Dorisio TM, Howe JR (2012) Comparison of clinicopathologic factors in 122 patients with resected pancreatic and ileal neuroendocrine tumors from a single institution. Ann Surg Oncol 19(3):966\u2013972. doi: 10.1245\/s10434-011-1997-4","journal-title":"Ann Surg Oncol"},{"key":"9681_CR32","author":"N Begum","year":"2013","unstructured":"Begum N, Hubold C, Buchmann I, Thorns C, Bouchard R, Lubienski A, Schloricke E, Zimmermann M, Lehnert H, Bruch HP, Burk CG (2013) Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary\u2014a plea for open exploration. Zentralbl Chir. doi: 10.1055\/s-0032-1327962","journal-title":"Zentralbl Chir"},{"issue":"3","key":"9681_CR33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1477-2574.2012.00528.x","volume":"15","author":"T Taner","year":"2013","unstructured":"Taner T, Atwell TD, Zhang L, Oberg TN, Harmsen WS, Slettedahl SW, Kendrick ML, Nagorney DM, Que FG (2013) Adjunctive radiofrequency ablation of metastatic neuroendocrine cancer to the liver complements surgical resection. HPB (Oxford) 15(3):190\u2013195. doi: 10.1111\/j.1477-2574.2012.00528.x","journal-title":"HPB (Oxford)"},{"issue":"5","key":"9681_CR34","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s00268-008-9510-3","volume":"32","author":"J Eriksson","year":"2008","unstructured":"Eriksson J, Stalberg P, Nilsson A, Krause J, Lundberg C, Skogseid B, Granberg D, Eriksson B, Akerstrom G, Hellman P (2008) Surgery and radiofrequency ablation for treatment of liver metastases from midgut and foregut carcinoids and endocrine pancreatic tumors. World J Surg 32(5):930\u2013938. doi: 10.1007\/s00268-008-9510-3","journal-title":"World J Surg"},{"issue":"2","key":"9681_CR35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000335587","volume":"95","author":"M Falconi","year":"2012","unstructured":"Falconi M, Bartsch DK, Eriksson B, Kloppel G, Lopes JM, O\u2019Connor JM, Salazar R, Taal BG, Vullierme MP, O\u2019Toole D (2012) ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology 95(2):120\u2013134. doi: 10.1159\/000335587","journal-title":"Neuroendocrinology"},{"issue":"2","key":"9681_CR36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000335629","volume":"95","author":"UF Pape","year":"2012","unstructured":"Pape UF, Perren A, Niederle B, Gross D, Gress T, Costa F, Arnold R, Denecke T, Plockinger U, Salazar R, Grossman A (2012) ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology 95(2):135\u2013156. doi: 10.1159\/000335629","journal-title":"Neuroendocrinology"},{"issue":"9","key":"9681_CR37","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1245\/s10434-013-3005-7","volume":"20","author":"EJ Kuo","year":"2013","unstructured":"Kuo EJ, Salem RR (2013) Population-level analysis of pancreatic neuroendocrine tumors 2\u00a0cm or less in size. Ann Surg Oncol 20(9):2815\u20132821. doi: 10.1245\/s10434-013-3005-7","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"9681_CR38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.surg.2012.08.038","volume":"152","author":"LC Lee","year":"2012","unstructured":"Lee LC, Grant CS, Salomao DR, Fletcher JG, Takahashi N, Fidler JL, Levy MJ, Huebner M (2012) Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management. Surgery 152(6):965\u2013974. doi: 10.1016\/j.surg.2012.08.038","journal-title":"Surgery"},{"issue":"2","key":"9681_CR39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","volume":"95","author":"M Pavel","year":"2012","unstructured":"Pavel M, Baudin E, Couvelard A, Krenning E, Oberg K, Steinmuller T, Anlauf M, Wiedenmann B, Salazar R (2012) ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 95(2):157\u2013176. doi: 10.1159\/000335597","journal-title":"Neuroendocrinology"},{"issue":"Suppl 2","key":"9681_CR40","first-page":"160A","volume":"27","author":"KM Stashek","year":"2014","unstructured":"Stashek KM, Czeczok TW, Bellizzi AM (2014) Extensive evaluation of immunohistochemistry to assign site of origin in well-differentiated neuroendocrine tumors: a study of 10 markers in 265 tumors. Mod Pathol 27(Suppl 2):160A","journal-title":"Mod Pathol"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-014-9681-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-014-9681-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-014-9681-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T14:40:02Z","timestamp":1559227202000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-014-9681-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,21]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["9681"],"URL":"https:\/\/doi.org\/10.1007\/s10585-014-9681-2","relation":{"is-referenced-by":[{"id-type":"doi","id":"10.1007\/s12672-025-03097-8","asserted-by":"object"}]},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,21]]}}}